Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

EU Risks Drug Shortages If API Import Regs Not Waived for US Says SOCMA

Europe could face drug shortages if the US is not granted exemption from new API import requirements, according to a US chemical industry trade association.

Related news

Sanofi has ended production at a historic London facility and says it plans to turn the site into a dedicated science park.

Phyton Biotech has received European approval for a version the cancer drug API docetaxel whose production does not rely on the scarce yew tree extract used in traditional manufacturing methods.  

Issues with GSK's Bottle Manufacturer Leads to MHRA Ventolin Alert

A GlaxoSmithKline subsidiary has issued a recall of two batches of Ventolin syrup in the UK after glass fragments were found in some bottles.

UK Moves to Prevent API Shortages Ahead of New EU Import Laws

The UK MHRA plans to let drugmakers import APIs that lack ‘written confirmation’ of quality if there is an overriding need to ensure continued supply.

Global Industry News

AMRI's Burlington Plant Given Controlled Substance Boost from DEA from Outsourcing-Pharma.com

The DEA has approved AMRI’s Burlington facility to work with Schedule 2 controlled substances, placing it in a competitive position to win contract manufacturing bids, the company says.

Pfizer Selects South African Trial Sites for Partnership Program from Outsourcing-Pharma.com

Pfizer has chosen three of Synexus' clinical research centres in South Africa to be a part of its 100-site INSPIRE programme based on the sites’ experience and audit history.

Wuxi to Help Develop, Manufacture ADC Candidate in China from Outsourcing-Pharma.com

Ambrx and Zhejiang Medicine have selected Wuxi to accelerate the development of a potential ADC (antibody drug conjugate) targeting Her2-positive breast cancer.

Parexel Backlog May Indicate Future Revenue Boom from Outsourcing-Pharma.com

CRO Parexel’s massive backlog could position the company for continued revenue growth moving forward, top executives said at recent conferences.

Spotlight

Confusion Abounds in Elemental Impurities Testing for Pharma, Excipients
Dispatches from Excipient Fest in Baltimore - UPDATE

Confusion Abounds in Elemental Impurities Testing for Pharma, Excipients

As the USP, ICH and US FDA all aim to tackle elemental impurities testing for pharmaceuticals and...

China Looks to Tighten Excipient Regulations with Limited Resources
Dispatches from Excipient Fest in Baltimore

China Looks to Tighten Excipient Regulations with Limited Resources

China’s implementation of GMPs for excipient manufacturers, as well as a developing US FDA-style DMF system, have...

Injex Gets China Approval; Glide to Make Solid-Dose Anthrax for Pfenex

Injex Gets China Approval; Glide to Make Solid-Dose Anthrax for Pfenex

Injex says it is looking for partners to prefill its device and Glide will develop Pfenex’s anthrax...

GMP Plants and BioPharma Clusters Drive Russia's Pharma 2020

GMP Plants and BioPharma Clusters Drive Russia's Pharma 2020

International GMP standard facilities and six biopharma centres will lead Russia’s initiative in implementing its Pharma 2020...